	US 11,653,649 B2
	Antimicrobial composition including a dihydroxamic acid and methods of inhibiting microbial growth utilizing the same
Scott W. Wenzel, Neenah, WI (US); Andrew R. Kischnick, Neenah, WI (US); Corey T. Cunningham, Neenah, WI (US); and Vinod Chaudhary, Neenah, WI (US)
Assigned to Kimberly-Clark Worldwide, Inc., Neenah, WI (US)
Appl. No. 16/623,427
Filed by Kimberly-Clark Worldwide, Inc., Neenah, WI (US)
PCT Filed Jun. 29, 2017, PCT No. PCT/US2017/039967 § 371(c)(1), (2) Date Dec. 17, 2019, PCT Pub. No. WO2019/005064, PCT Pub. Date Jan. 3, 2019.
Prior Publication US 2020/0120929 A1, Apr. 23, 2020
Int. Cl. A01N 37/28 (2006.01); A01N 25/24 (2006.01); A01N 25/04 (2006.01); A01N 25/34 (2006.01)

CPC A01N 37/28 (2013.01) [A01N 25/04 (2013.01); A01N 25/34 (2013.01)]

6 Claims

1. A method for inhibiting microbial growth in a product, the method comprising:

providing a composition including an antimicrobial agent, the antimicrobial agent comprising N, N′, 2-trihydroxy butane diamide and a cLogP value less than 0.50;

applying the composition to the product to inhibit microbial growth, wherein the antimicrobial agent comprises a MIC efficacy level of less than 1.0% according to the Minimum Inhibitory Concentration Test against at least one of Staphylococcus aureus, Escherichia coli, Burkholderia cepacia, Pseudomonas aeruginosa, Candida albicans, and Aspergillus brasiliensis.